A phase 2 trial to evaluate the efficacy and safety of orally-administered LEO 152020 tablets compared with placebo tablets for up to 16 weeks of treatment in adults with moderate to severe atopic dermatitis

  • Sharma, Niyati (Primary Chief Investigator (PCI))

Project: Research

Project Details

Effective start/end date8/02/227/02/27


  • phase 2 trial
  • dermatology
  • treatment efficacy